. | Incidence/100 000/ annum . | Number of years between consecutive new cases seen by a general practitioner with a list size of 2000 people . |
---|---|---|
Stroke | 200 | 0.25 |
Carpal tunnel syndrome | 100 | 0.5 |
First epileptic (non-febrile) seizure | 50 | 1.0 |
Transient ischaemic attack | 50 | 1.0 |
Bell’s palsy | 25 | 2.0 |
Essential tremor | 24 | 2.1 |
Parkinson’s disease | 20 | 2.5 |
Primary brain tumour | 15 | 3.3 |
Secondary brain tumour | 14 | 3.6 |
Multiple sclerosis (Scotland) | 12 | 4.2 |
Subarachnoid haemorrhage | 10 | 5.0 |
Essential tremor | 8 | 6.3 |
Giant cell arteritis | 6 | 8.3 |
Migrainous neuralgia | 6 | 8.3 |
Unexplained motor symptoms | 5 | 10 |
Trigeminal neuralgia | 4 | 13 |
Meningococcal meningitis (UK) | 3 | 17 |
Transient global amnesia | 3 | 17 |
Guillain–Barré syndrome | 2 | 25 |
Intracranial vascular malformation | 2 | 25 |
Motor neurone disease | 2 | 25 |
Neuralgic amyotrophy | 2 | 25 |
Progressive supranuclear palsy | 1 | 50 |
Diabetic amyotrophy | 1 | 50 |
Benign intracranial hypertension | 1 | 50 |
Focal dystonia | 1 | 50 |
Myasthenia gravis | 1 | 50 |
Polymyositis/dermatomyositis | 1 | 50 |
Hemifacial spasm | 0.8 | 63 |
Multiple system atrophy | 0.6 | 83 |
Gilles de la Tourette syndrome | 0.5 | 100 |
Pneumococcal meningitis (UK) | 0.5 | 100 |
Herpes simplex encephalitis | 0.2 | 250 |
Creutzfeldt–Jakob disease (sporadic) | 0.1 | 500 |
Tetanus | 0.1 | 500 |
Subacute sclerosing panencephalitis | 0.03 | 1667 |
Variant Creutzfeldt–Jakob disease (UK) | 0.02 | 2500 |
. | Incidence/100 000/ annum . | Number of years between consecutive new cases seen by a general practitioner with a list size of 2000 people . |
---|---|---|
Stroke | 200 | 0.25 |
Carpal tunnel syndrome | 100 | 0.5 |
First epileptic (non-febrile) seizure | 50 | 1.0 |
Transient ischaemic attack | 50 | 1.0 |
Bell’s palsy | 25 | 2.0 |
Essential tremor | 24 | 2.1 |
Parkinson’s disease | 20 | 2.5 |
Primary brain tumour | 15 | 3.3 |
Secondary brain tumour | 14 | 3.6 |
Multiple sclerosis (Scotland) | 12 | 4.2 |
Subarachnoid haemorrhage | 10 | 5.0 |
Essential tremor | 8 | 6.3 |
Giant cell arteritis | 6 | 8.3 |
Migrainous neuralgia | 6 | 8.3 |
Unexplained motor symptoms | 5 | 10 |
Trigeminal neuralgia | 4 | 13 |
Meningococcal meningitis (UK) | 3 | 17 |
Transient global amnesia | 3 | 17 |
Guillain–Barré syndrome | 2 | 25 |
Intracranial vascular malformation | 2 | 25 |
Motor neurone disease | 2 | 25 |
Neuralgic amyotrophy | 2 | 25 |
Progressive supranuclear palsy | 1 | 50 |
Diabetic amyotrophy | 1 | 50 |
Benign intracranial hypertension | 1 | 50 |
Focal dystonia | 1 | 50 |
Myasthenia gravis | 1 | 50 |
Polymyositis/dermatomyositis | 1 | 50 |
Hemifacial spasm | 0.8 | 63 |
Multiple system atrophy | 0.6 | 83 |
Gilles de la Tourette syndrome | 0.5 | 100 |
Pneumococcal meningitis (UK) | 0.5 | 100 |
Herpes simplex encephalitis | 0.2 | 250 |
Creutzfeldt–Jakob disease (sporadic) | 0.1 | 500 |
Tetanus | 0.1 | 500 |
Subacute sclerosing panencephalitis | 0.03 | 1667 |
Variant Creutzfeldt–Jakob disease (UK) | 0.02 | 2500 |
These figures are all very approximate. They have been taken from various more or less sound community-based epidemiological studies in Europe or North America and a large survey of general practice in the United Kingdom (MacDonald et al. 2000). When more than one study is available, an approximate average rate has been used. The exact rates will generally depend on the age and sex structure of the population, which varies between communities, the size of the population which will influence the precision of any estimate, and on the precise diagnostic criteria which also vary. However, the rates give a general idea of incidence and how common, or rare, some neurological disorders are.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.